|
OxyContin Information:
FDA Strengthens Warnings for OxyContin
FDA has strengthened the warnings and precautions sections in the labeling of OxyContin
(oxycodone HCl controlled-release) Tablets, a narcotic drug approved for the treatment of
moderate to severe pain.
In recent months, there have been numerous reports of OxyContin diversion and abuse in
several states. Some of these reported cases have been associated with serious
consequences including death. In an effort to educate health care providers about these
risks, Purdue Pharmaceuticals, manufacturer of the product, has issued a warning in the
form of a "Dear Healthcare Professional" letter. The "Dear Healthcare
Professional" letter will be distributed widely to physicians, pharmacists, and other
healthcare professionals.
Back to Top
Back to Drug Information
PDF requires the free Adobe Acrobat Reader
Date created: January 22, 2004, updated June 26, 2006 |
|